The Effect of Walnut Oil Consumption on Blood Sugar in Patients With Diabetes Mellitus Type 2

Overview

Journal Int J Endocrinol Metab

Publisher Brieflands

Specialty Endocrinology

Date 2017 Jan 25

PMID 28115966

Citations 10

Authors

MohammadJavad Zibaeenezhad

Kamran Aghasadeghi

Hossein Hakimi

Hassan Yarmohammadi

Farzad Nikaein

Affiliations

Soon will be listed here.

Abstract

Background: Prevalence of diabetes mellitus type 2 (DM) is increasing globally. Considering the potential role of poly-unsaturated fatty acids in prevention of DM type 2 and lipid profiles improvement, some studies have been carried out on walnut. However, there are no studies on control of blood sugar in DM type 2 patients using walnut.

Objectives: The current study aimed to evaluate the effect of walnut oil on blood sugar in DM type 2 patients.

Methods: This randomized control clinical trial was performed on 100 patients with DM type 2. For the experiment group (n = 50), walnut oil (15 g/day for three months) was added to their diet, while the control group (n = 50) did not undergo any interventions. Before initiation of the experiment and after the experiment, the systolic and diastolic blood pressure (SBP and DBP) levels, fasting blood sugar (FBS) and HbA1c were measured.

Results: The two groups were not significantly different for SBP, DBP, body weight, and Body Mass Index. HbA1c level decreased significantly in the experiment group by 7.86% ± 21.97 (P = 0.005) from 7.00 ± 1.08 before the intervention to 6.37 ± 1.29 after the intervention. Also, FBS level decreased significantly by 8.24% ± 16.77 (P = 0.001); from 158.37 ± 48.16 before the intervention to 137.91 ± 23.24 after the intervention in the experimental group. These changes in the control group were not significant.

Conclusions: Consumption of walnut oil (15 g/day for three months) was shown to improve blood glucose level but, no changes were noted for bodyweight and blood pressure in type two diabetic patients.

Citing Articles

Tree Nut and Peanut Consumption and Risk of Cardiovascular Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Houston L, Probst Y, Chandra Singh M, Neale E Adv Nutr. 2023; 14(5):1029-1049.

PMID: 37149262 PMC: 10509427. DOI: 10.1016/j.advnut.2023.05.004.

The Effect of Walnut Intake on Lipids: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Alshahrani S, Mashat R, Almutairi D, Mathkour A, Alqahtani S, Alasmari A Nutrients. 2022; 14(21).

PMID: 36364723 PMC: 9655834. DOI: 10.3390/nu14214460.

Effectiveness and Safety of Ayurvedic Medicines in Type 2 Diabetes Mellitus Management: A Systematic Review and Meta-Analysis.

Chattopadhyay K, Wang H, Kaur J, Nalbant G, Almaqhawi A, Kundakci B Front Pharmacol. 2022; 13:821810.

PMID: 35754481 PMC: 9213670. DOI: 10.3389/fphar.2022.821810.

The Relationship of Tree Nuts and Peanuts with Adiposity Parameters: A Systematic Review and Network Meta-Analysis.

Fernandez-Rodriguez R, Mesas A, Garrido-Miguel M, Martinez-Ortega I, Jimenez-Lopez E, Martinez-Vizcaino V Nutrients. 2021; 13(7).

PMID: 34208812 PMC: 8308485. DOI: 10.3390/nu13072251.

Walnut intake, cognitive outcomes and risk factors: a systematic review and meta-analysis.

Cahoon D, Shertukde S, Avendano E, Tanprasertsuk J, Scott T, Johnson E Ann Med. 2021; 53(1):971-997.

PMID: 34132152 PMC: 8211141. DOI: 10.1080/07853890.2021.1925955.

References

Ma Y, Njike V, Millet J, Dutta S, Doughty K, Treu J . Effects of walnut consumption on endothelial function in type 2 diabetic subjects: a randomized controlled crossover trial. Diabetes Care. 2009; 33(2):227-32. PMC: 2809254. DOI: 10.2337/dc09-1156. View

Riserus U, Willett W, Hu F . Dietary fats and prevention of type 2 diabetes. Prog Lipid Res. 2008; 48(1):44-51. PMC: 2654180. DOI: 10.1016/j.plipres.2008.10.002. View

Franz M, Bantle J, Beebe C, Brunzell J, Chiasson J, Garg A . Evidence-based nutrition principles and recommendations for the treatment and prevention of diabetes and related complications. Diabetes Care. 2002; 26 Suppl 1:S51-61. DOI: 10.2337/diacare.26.2007.s51. View

Moloney F, Toomey S, Noone E, Nugent A, Allan B, Loscher C . Antidiabetic effects of cis-9, trans-11-conjugated linoleic acid may be mediated via anti-inflammatory effects in white adipose tissue. Diabetes. 2007; 56(3):574-82. DOI: 10.2337/db06-0384. View

Dreher M, Maher C, Kearney P . The traditional and emerging role of nuts in healthful diets. Nutr Rev. 1996; 54(8):241-5. DOI: 10.1111/j.1753-4887.1996.tb03941.x. View

Njike V, Ayettey R, Petraro P, Treu J, Katz D . Walnut ingestion in adults at risk for diabetes: effects on body composition, diet quality, and cardiac risk measures. BMJ Open Diabetes Res Care. 2015; 3(1):e000115. PMC: 4679815. DOI: 10.1136/bmjdrc-2015-000115. View

Pan W, Cedres L, Liu K, Dyer A, SCHOENBERGER J, SHEKELLE R . Relationship of clinical diabetes and asymptomatic hyperglycemia to risk of coronary heart disease mortality in men and women. Am J Epidemiol. 1986; 123(3):504-16. DOI: 10.1093/oxfordjournals.aje.a114266. View

Yochum L, Folsom A, Kushi L . Intake of antioxidant vitamins and risk of death from stroke in postmenopausal women. Am J Clin Nutr. 2000; 72(2):476-83. DOI: 10.1093/ajcn/72.2.476. View

Reiter R, Manchester L, Tan D . Melatonin in walnuts: influence on levels of melatonin and total antioxidant capacity of blood. Nutrition. 2005; 21(9):920-4. DOI: 10.1016/j.nut.2005.02.005. View

10.

Anderson K, Teuber S, Gobeille A, Cremin P, Waterhouse A, Steinberg F . Walnut polyphenolics inhibit in vitro human plasma and LDL oxidation. J Nutr. 2001; 131(11):2837-42. DOI: 10.1093/jn/131.11.2837. View

11.

Kushi L, Folsom A, Prineas R, Mink P, Wu Y, Bostick R . Dietary antioxidant vitamins and death from coronary heart disease in postmenopausal women. N Engl J Med. 1996; 334(18):1156-62. DOI: 10.1056/NEJM199605023341803. View

12.

Barrett-Connor E, Wingard D . Sex differential in ischemic heart disease mortality in diabetics: a prospective population-based study. Am J Epidemiol. 1983; 118(4):489-96. DOI: 10.1093/oxfordjournals.aje.a113654. View

13.

Wu X, Beecher G, Holden J, Haytowitz D, Gebhardt S, Prior R . Lipophilic and hydrophilic antioxidant capacities of common foods in the United States. J Agric Food Chem. 2004; 52(12):4026-37. DOI: 10.1021/jf049696w. View

14.

Pan A, Sun Q, Manson J, Willett W, Hu F . Walnut consumption is associated with lower risk of type 2 diabetes in women. J Nutr. 2013; 143(4):512-8. PMC: 3738245. DOI: 10.3945/jn.112.172171. View

15.

Ansar H, Mazloom Z, Kazemi F, Hejazi N . Effect of alpha-lipoic acid on blood glucose, insulin resistance and glutathione peroxidase of type 2 diabetic patients. Saudi Med J. 2011; 32(6):584-8. View

16.

Sabate J, Oda K, Ros E . Nut consumption and blood lipid levels: a pooled analysis of 25 intervention trials. Arch Intern Med. 2010; 170(9):821-7. DOI: 10.1001/archinternmed.2010.79. View

17.

Fukuda T, Ito H, Yoshida T . Antioxidative polyphenols from walnuts (Juglans regia L.). Phytochemistry. 2003; 63(7):795-801. DOI: 10.1016/s0031-9422(03)00333-9. View

18.

. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2003; 27 Suppl 1:S5-S10. DOI: 10.2337/diacare.27.2007.s5. View

19.

Kris-Etherton P, Zhao G, Binkoski A, Coval S, Etherton T . The effects of nuts on coronary heart disease risk. Nutr Rev. 2001; 59(4):103-11. DOI: 10.1111/j.1753-4887.2001.tb06996.x. View

20.

Campmans-Kuijpers M, Sluijs I, Nothlings U, Freisling H, Overvad K, Boeing H . The association of substituting carbohydrates with total fat and different types of fatty acids with mortality and weight change among diabetes patients. Clin Nutr. 2015; 35(5):1096-102. DOI: 10.1016/j.clnu.2015.08.003. View